Coffee consumption and cardiovascular health: Getting to the heart of the matter topical collection on ischemic heart disease

Current Cardiology Reports

Volumn 15, Issue 10, 2013, Pages

  Rebello, Salome A ^a   Van Dam, Rob M ^b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Arrhythmias; Blood lipids; Blood pressure; Cardiovascular mortality; Coffee; Coronary heart disease; Heart failure; Homocysteine; Inflammation; Insulin resistance; Stroke; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; COFFEE; LIPID;

ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COFFEE; DISEASE ASSOCIATION; FOOD INTAKE; HEART FAILURE; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFLAMMATION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; META ANALYSIS (TOPIC); MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING; BLOOD; CARDIOVASCULAR DISEASES; DRUG EFFECTS; EVIDENCE BASED MEDICINE; FOOD HANDLING; PROCEDURES; RISK ASSESSMENT;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COFFEE; EVIDENCE-BASED MEDICINE; FOOD HANDLING; HUMANS; LIPIDS; META-ANALYSIS AS TOPIC; RISK ASSESSMENT;

EID: 84896587287     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-013-0403-1     Document Type: Article

References (101)

1. • Beaudoin MS, Graham TE. Methylxanthines and human health: epidemiological and experimental evidence. Handb Exp Pharmacol. 2011:509-48. This article summarizes the evidence on the effects of caffeine on glucose homeostasis and provides details on potential mechanisms of actions.
2. Noordzij M, Uiterwaal CS, Arends LR, et al. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens. 2005;23:921-8. (Pubitemid 40637906)
3. • Pelchovitz DJ, Goldberger JJ. Caffeine and cardiac arrhythmias: a review of the evidence. Am J Med. 2011;124:284-9. This article summarizes the evidence on the effects of caffeine and coffee on arrthymia.
4. Kawachi I, Colditz GA, Stone CB. Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. Br Heart J. 1994;72:269-75.
5. Sofi F, Conti AA, Gori AM, et al. Coffee consumption and risk of coronary heart disease: a meta-analysis. Nutr Metab Cardiovasc Dis. 2007;17:209-23. (Pubitemid 46400413)
6. •• Wu JN, Ho SC, Zhou C, et al. Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. Int J Cardiol. 2009;137:216-25. This meta-analysis of prospective studies observed that coffee consumption was not associated with risk of coronary heart disease.
7. van Dam RM. Coffee consumption and coronary heart disease: paradoxical effects on biological risk factors vs disease incidence. Clin Chem. 2008;54:1418-20.
8. Tunnicliffe JM, Shearer J. Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Appl Physiol Nutr Metab. 2008;33:1290-300.
9. Kempf K, Herder C, Erlund I, et al. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr. 2010;91:950-7.
10. Wedick NM, Brennan AM, Sun Q, et al. Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial. Nutr J. 2011;10:93.
11. Williams CJ, Fargnoli JL, Hwang JJ, et al. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care. 2008;31:504-7.
12. •• Huxley R, Lee CM, Barzi F, et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med. 2009;169:2053-63. This meta-analysis of prospective studies observed that coffee consumption was associated with a lower risk of type-2 diabetes.
13. •• Zhang Z, Hu G, Caballero B, et al. Habitual coffee consumption and risk of hypertension: a systematic review and meta-analysis of prospective observational studies. Am J Clin Nutr. 2011;93:1212-9. This meta-analysis of prospective studies observed that habitual coffee consumption was modestly associated with a higher risk of hypertension.
14. •• Mostofsky E, Rice MS, Levitan EB, Mittleman MA. Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis. Circ Heart Fail. 2012;5:401-5. This meta-analyses of prospective studies observed that habitual coffee consumption was weakly associated with a lower risk of heart-failure.
15. •• Mesas AE, Leon-Munoz LM, Rodriguez-Artalejo F, Lopez-Garcia E. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr. 2011;94:1113-26. This paper shows that caffiene intake increases blood pressure in hypertensive individuals for at least 3 hours after intake.
16. •• Larsson SC, Orsini N. Coffee consumption and risk of stroke: a dose-response meta-analysis of prospective studies. Am J Epidemiol. 2011;174:993-1001. This meta-analysis of prospective studies observed that habitual coffee consumption was weakly associated with a lower risk of stroke.
17. •• Cai L, Ma D, Zhang Y, et al. The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2012;66:872-7. This meta-analysis of randomized-trials shows that unfiltered types of coffee increases circulating levels of LDL cholesterol and triglycerides. Much smaller and nonsignificant increases in plasma LDL cholesterol and triglycerides concentrations were noted with filtered coffee intake.
18. •• Steffen M, Kuhle C, Hensrud D, et al. The effect of coffee consumption on blood pressure and the development of hypertension: a systematic review and meta-analysis. J Hypertens. 2012;30:2245-54. This meta-analysis of randomized trials showed that coffee consumption did not increase blood pressure as compared with not consuming coffee or consuming lower amounts of coffee. Significant heterogenity for changes in systolic blood pressure was observed which was not explained by differences due to type of coffee (caffeinated or decaffeinated), prepartion method (boiled, instant or filtered), hypertension status or sex.
19. Moreira AS, Nunes FM, Domingues MR, Coimbra MA. Coffee melanoidins: structures, mechanisms of formation and potential health impacts. Food Funct. 2012;3:903-15.
20. Farah A. Coffee constituents. In: Chu YF, editor. Coffee: emerging health effects and disease prevention. Iowa: Wiley-Blackwell/IFT Press; 2012. p. 22-57.
21. Casal S, Oliveira MB, Alves MR, Ferreira MA. Discriminate analysis of roasted coffee varieties for trigonelline, nicotinic acid, and caffeine content. J Agric Food Chem. 2000;48:3420-4.
22. Urgert R, Essed N, van der Weg G, et al. Separate effects of the coffee diterpenes cafestol and kahweol on serum lipids and liver aminotransferases. Am J Clin Nutr. 1997;65:519-24. (Pubitemid 27130762)
23. Urgert R, Katan MB. The cholesterol-raising factor from coffee beans. Annu Rev Nutr. 1997;17:305-24. (Pubitemid 27328803)
24. Heckman MA, Weil J, Gonzalez de Mejia E. Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci. 2010;75:R77-87.
25. Nurminen ML, Niittynen L, Korpela R, Vapaatalo H. Coffee, caffeine and blood pressure: a critical review. Eur J Clin Nutr. 1999;53:831-9. (Pubitemid 29532988)
26. Varani K, Portaluppi F, Gessi S, et al. Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors: functional and biochemical aspects. Circulation. 2000;102:285-9. (Pubitemid 30457577)
27. Rakic V, Burke V, Beilin LJ. Effects of coffee on ambulatory blood pressure in older men and women: a randomized controlled trial. Hypertension. 1999;33:869-73. (Pubitemid 29140448)
28. Geleijnse JM. Habitual coffee consumption and blood pressure: an epidemiological perspective. Vasc Health Risk Manag. 2008;4:963-70.
29. de Paulis T, Schmidt DE, Bruchey AK, et al. Dicinnamoylquinides in roasted coffee inhibit the human adenosine transporter. Eur J Pharmacol. 2002;442:215-23. (Pubitemid 34626196)
30. Watanabe T, Arai Y, Mitsui Y, et al. The blood pressure-lowering effect and safety of chlorogenic acid from green coffee bean extract in essential hypertension. Clin Exp Hypertens. 2006;28:439-49. (Pubitemid 44034669)
31. Mubarak A, Bondonno CP, Liu AH, et al. Acute effects of chlorogenic acid on nitric oxide status, endothelial function, and blood pressure in healthy volunteers: a randomized trial. J Agric Food Chem. 2012;60:9130-6.
32. Zhao Y, Wang J, Ballevre O, et al. Antihypertensive effects and mechanisms of chlorogenic acids. Hypertens Res. 2012;35:370-4.
33. Chikama A, Yamaguchi T, Ochiai R, et al. Effects of hydroxyhydroquinone- reduced coffee on blood pressure in high-normotensives and mild hypertensives. J Health Sci. 2008;54:162-73. (Pubitemid 351758484)
34. Yamaguchi T, Chikama A, Mori K, et al. Hydroxyhydroquinone-free coffee: a double-blind, randomized controlled dose-response study of blood pressure. Nutr Metab Cardiovasc Dis. 2008;18:408-14. (Pubitemid 351899106)
35. Natella F, Scaccini C. Role of coffee in modulation of diabetes risk. Nutr Rev. 2012;70:207-17.
36. Correa TA, Monteiro MP, Mendes TM, et al. Medium light and medium roast paper-filtered coffee increased antioxidant capacity in healthy volunteers: results of a randomized trial. Plant Foods Hum Nutr. 2012;67:277-82.
37. Bichler J, Cavin C, Simic T, et al. Coffee consumption protects human lymphocytes against oxidative and 3-amino-1-methyl-5H-pyrido[4,3-b]indole acetate (Trp-P-2) induced DNA-damage: results of an experimental study with human volunteers. Food Chem Toxicol. 2007;45:1428-36. (Pubitemid 47033947)
38. Bakuradze T, Boehm N, Janzowski C, et al. Antioxidant-rich coffee reduces DNA damage, elevates glutathione status and contributes to weight control: results from an intervention study. Mol Nutr Food Res. 2011;55:793-7.
39. Hoelzl C, Knasmuller S, Wagner KH, et al. Instant coffee with high chlorogenic acid levels protects humans against oxidative damage of macromolecules. Mol Nutr Food Res. 2010;54:1722-33.
40. Natella F, Nardini M, Belelli F, Scaccini C. Coffee drinking induces incorporation of phenolic acids into LDL and increases the resistance of LDL to ex vivo oxidation in humans. Am J Clin Nutr. 2007;86:604-9. (Pubitemid 47435826)
41. Maki T, Pham NM, Yoshida D, et al. The relationship of coffee and green tea consumption with high-sensitivity C-reactive protein in Japanese men and women. Clin Chem Lab Med. 2010;48:849-54.
42. Rebello SA, Chen CH, Naidoo N, et al. Coffee and tea consumption in relation to inflammation and basal glucose metabolism in a multi-ethnic Asian population: a cross-sectional study. Nutr J. 2011;10:61.
43. Zampelas A, Panagiotakos DB, Pitsavos C, et al. Associations between coffee consumption and inflammatory markers in healthy persons: the ATTICA study. Am J Clin Nutr. 2004;80:862-7. (Pubitemid 41202083)
44. Lopez-Garcia E, van Dam RM, Qi L, Hu FB. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr. 2006;84:888-93. (Pubitemid 44715672)
45. Yamashita K, Yatsuya H, Muramatsu T, et al. Association of coffee consumption with serum adiponectin, leptin, inflammation and metabolic markers in Japanese workers: a cross-sectional study. Nutr Diabetes. 2012;2:e33.
46. Imatoh T, Tanihara S, Miyazaki M, et al. Coffee consumption but not green tea consumption is associated with adiponectin levels in Japanese males. Eur J Nutr. 2011;50:279-84.
47. Saito M, Nemoto T, Tobimatsu S, et al. Coffee consumption and cystatin-C-based estimated glomerular filtration rates in healthy young adults: results of a clinical trial. J Nutr Metab. 2011;2011:146865.
48. van Woudenbergh GJ, Vliegenthart R, van Rooij FJ, et al. Coffee consumption and coronary calcification: the Rotterdam Coronary Calcification Study. Arterioscler Thromb Vasc Biol. 2008;28:1018-23. (Pubitemid 351544122)
49. Reis JP, Loria CM, Steffen LM, et al. Coffee, decaffeinated coffee, caffeine, and tea consumption in young adulthood and atherosclerosis later in life: the CARDIA study. Arterioscler Thromb Vasc Biol. 2010;30:2059-66.
50. van Dam RM. Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer. Appl Physiol Nutr Metab. 2008;33:1269-83.
51. Goto A, Song Y, Chen BH, et al. Coffee and caffeine consumption in relation to sex hormone-binding globulin and risk of type 2 diabetes in postmenopausal women. Diabetes. 2011;60:269-75.
52. Zhang Y, Lee ET, Cowan LD, et al. Coffee consumption and the incidence of type 2 diabetes in men and women with normal glucose tolerance: the Strong Heart Study. Nutr Metab Cardiovasc Dis. 2011;21:418-23.
53. Bhupathiraju SN, Pan A, Malik VS, et al. Caffeinated and caffeine-free beverages and risk of type 2 diabetes. Am J Clin Nutr. 2013;97:155-66.
54. van Dam RM. Coffee and type 2 diabetes: from beans to beta-cells. Nutr Metab Cardiovasc Dis. 2006;16:69-77.
55. Ohnaka K, Ikeda M, Maki T, et al. Effects of 16-week consumption of caffeinated and decaffeinated instant coffee on glucose metabolism in a randomized controlled trial. J Nutr Metab. 2012;2012:207426.
56. Whitehead N, White H. Systematic review of randomised controlled trials of the effects of caffeine or caffeinated drinks on blood glucose concentrations and insulin sensitivity in people with diabetes mellitus. J Hum Nutr Dietet. 2013;26(2):111-25.
57. Urgert R, van Vliet T, Zock PL, Katan MB. Heavy coffee consumption and plasma homocysteine: a randomized controlled trial in healthy volunteers. Am J Clin Nutr. 2000;72:1107-10.
58. Grubben MJ, Boers GH, Blom HJ, et al. Unfiltered coffee increases plasma homocysteine concentrations in healthy volunteers: a randomized trial. Am J Clin Nutr. 2000;71:480-4. (Pubitemid 30061226)
59. Verhoef P, Pasman WJ, Van Vliet T, et al. Contribution of caffeine to the homocysteine-raising effect of coffee: a randomized controlled trial in humans. Am J Clin Nutr. 2002;76:1244-8. (Pubitemid 35416558)
60. Olthof MR, Hollman PC, Zock PL, Katan MB. Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans. Am J Clin Nutr. 2001;73:532-8. (Pubitemid 32176503)
61. Panagiotakos DB, Pitsavos C, Zampelas A, et al. The association between coffee consumption and plasma total homocysteine levels: the «ATTICA» study. Heart Vessels. 2004;19:280-6. (Pubitemid 39600420)
62. Marti-Carvajal AJ, Sola I, Lathyris D, Salanti G. Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2009;CD006612.
63. Qin X, Huo Y, Xie D, et al. Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: a meta-analysis of randomized controlled trials. Clin Nutr. 2012;S0261-5614(12):00280-4.
64. Lopez-Garcia E, Rodriguez-Artalejo F, Li TY, et al. Coffee consumption and mortality in women with cardiovascular disease. Am J Clin Nutr. 2011;94:218-24.
65. Mineharu Y, Koizumi A, Wada Y, et al. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health. 2011;65:230-40.
66. Klatsky AL, Koplik S, Kipp H, Friedman GD. The confounded relation of coffee drinking to coronary artery disease. Am J Cardiol. 2008;101:825-7.
67. Gurpegui M, Jurado D, Luna JD, et al. Personality traits associated with caffeine intake and smoking. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:997-1005. (Pubitemid 46810089)
68. Mukamal KJ, Hallqvist J, Hammar N, et al. Coffee consumption and mortality after acute myocardial infarction: the Stockholm Heart Epidemiology Program. Am Heart J. 2009;157:495-501.
69. Cornelis MC. Coffee intake. Prog Mol Biol Transl Sci. 2012;108:293-322.
70. Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA. 2006;295:1135-41. (Pubitemid 43352342)
71. Palatini P, Ceolotto G, Ragazzo F, et al. CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension. J Hypertens. 2009;27:1594-601.
72. Floegel A, Pischon T, Bergmann MM, et al. Coffee consumption and risk of chronic disease in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany study. Am J Clin Nutr. 2012;95:901-8.
73. LaCroix AZ, Mead LA, Liang KY, et al. Coffee consumption and the incidence of coronary heart disease. N Engl J Med. 1986;315:977-82. (Pubitemid 16028577)
74. Lopez-Garcia E, van Dam RM, Willett WC, et al. Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation. 2006;113:2045-53.
75. de Koning Gans JM, Uiterwaal CS, van der Schouw YT, et al. Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol. 2010;30:1665-71.
76. Sugiyama K, Kuriyama S, Akhter M, et al. Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women. J Nutr. 2010;140:1007-13.
77. Freedman ND, Park Y, Abnet CC, et al. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 2012;366:1891-904.
78. Lopez-Garcia E, van Dam RM, Li TY, et al. The relationship of coffee consumption with mortality. Ann Intern Med. 2008;148:904-14. (Pubitemid 351860822)
79. Leurs LJ, Schouten LJ, Goldbohm RA, van den Brandt PA. Total fluid and specific beverage intake and mortality due to IHD and stroke in The Netherlands Cohort Study. Br J Nutr. 2010;104:1212-21.
80. Kokubo Y, Iso H, Saito I, et al. The impact of green tea and coffee consumption on the reduced risk of stroke incidence in Japanese population: The Japan Public Health Center-Based Study Cohort. Stroke. 2013;44(5):1369-74.
81. Lopez-Garcia E, Rodriguez-Artalejo F, Rexrode KM, et al. Coffee consumption and risk of stroke in women. Circulation. 2009;119:1116-23.
82. Riksen NP, Rongen GA, Smits P. Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease. Pharmacol Ther. 2009;121:185-91.
83. de Vreede-Swagemakers JJ, Gorgels AP, Weijenberg MP, et al. Risk indicators for out-of-hospital cardiac arrest in patients with coronary artery disease. J Clin Epidemiol. 1999;52:601-7. (Pubitemid 29284817)
84. Mukamal KJ, Maclure M, Muller JE, et al. Caffeinated coffee consumption and mortality after acute myocardial infarction. Am Heart J. 2004;147:999-1004. (Pubitemid 38880954)
85. Silletta MG, Marfisi R, Levantesi G, et al. Coffee consumption and risk of cardiovascular events after acute myocardial infarction: results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione trial. Circulation. 2007;116:2944-51. (Pubitemid 350291201)
86. Zhang W, Lopez-Garcia E, Li TY, et al. Coffee consumption and risk of cardiovascular diseases and all-cause mortality among men with type 2 diabetes. Diabetes Care. 2009;32:1043-5.
87. Zhang WL, Lopez-Garcia E, Li TY, et al. Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes. Diabetologia. 2009;52:810-7.
88. Bidel S, Hu G, Qiao Q, et al. Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes. Diabetologia. 2006;49:2618-26. (Pubitemid 44559523)
89. Baylin A, Hernandez-Diaz S, Kabagambe EK, et al. Transient exposure to coffee as a trigger of a first nonfatal myocardial infarction. Epidemiology. 2006;17:506-11. (Pubitemid 44223057)
90. Mostofsky E, Schlaug G, Mukamal KJ, et al. Coffee and acute ischemic stroke onset: the Stroke Onset Study. Neurology. 2010;75:1583-8.
91. Selb Semerl J, Selb K. Coffee and alcohol consumption as triggering factors for sudden cardiac death: case-crossover study. Croat Med J. 2004;45:775-80. (Pubitemid 40063582)
92. Mittleman MA, Mostofsky E. Physical, psychological and chemical triggers of acute cardiovascular events: preventive strategies. Circulation. 2011;124:346-54.
93. Perera V, Gross AS, McLachlan AJ. Influence of environmental and genetic factors on CYP1A2 activity in individuals of South Asian and European ancestry. Clin Pharmacol Ther. 2012;92:511-9.
94. Bernstein AM, de Koning L, Flint AJ, et al. Soda consumption and the risk of stroke in men and women. Am J Clin Nutr. 2012;95:1190-9.
95. Pan A, Malik VS, Hao T, et al. Changes in water and beverage intake and long-term weight changes: results from three prospective cohort studies. Int J Obes (Lond). 2013.
96. Mensink RP, Lebbink WJ, Lobbezoo IE, et al. Diterpene composition of oils from Arabica and Robusta coffee beans and their effects on serum lipids in man. J Intern Med. 1995;237:543-50.
97. Moon JK, Yoo HS, Shibamoto T. Role of roasting conditions in the level of chlorogenic acid content in coffee beans: correlation with coffee acidity. J Agric Food Chem. 2009;57:5365-9.
98. Naidoo N, Chen C, Rebello SA, et al. Cholesterol-raising diterpenes in types of coffee commonly consumed in Singapore, Indonesia and India and associations with blood lipids: a survey and cross sectional study. Nutr J. 2011;10:48.
99. International Food Information Council. Caffeine and Health, Clarifying the controversies. Available at: http://www.foodinsight.org/Content/3147/ Caffeine-v8-2.pdf. Accessed January 2013.
100. Crozier TW, Stalmach A, Lean ME, Crozier A. Espresso coffees, caffeine and chlorogenic acid intake: potential health implications. Food Funct. 2012;3:30-3.
101. Boekschoten MV, van Cruchten ST, Kosmeijer-Schuil TG, Katan MB. Negligible amounts of cholesterol-raising diterpenes in coffee made with coffee pads in comparison with unfiltered coffee. Ned Tijdschr Geneeskd. 2006;150:2873-5. (Pubitemid 46132467)